A detailed history of Simplex Trading, LLC transactions in Compass Pathways PLC stock. As of the latest transaction made, Simplex Trading, LLC holds 101,258 shares of CMPS stock, worth $864,743. This represents 0.03% of its overall portfolio holdings.

Number of Shares
101,258
Previous 21,492 371.14%
Holding current value
$864,743
Previous $183,000 372.13%
% of portfolio
0.03%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
N/A
79,766 Added 371.14%
101,258 $864,000
Q2 2024

Jul 25, 2024

BUY
N/A
17,158 Added 395.89%
21,492 $183,000
Q1 2024

Apr 25, 2024

SELL
N/A
-6,788 Reduced 61.03%
4,334 $37,000
Q4 2023

Feb 02, 2024

BUY
N/A
10,606 Added 2055.43%
11,122 $97,000
Q3 2023

Nov 01, 2023

SELL
N/A
-1,611 Reduced 75.74%
516 $4,000
Q2 2023

Aug 04, 2023

BUY
$7.79 - $10.69 $16,569 - $22,737
2,127 New
2,127 $18,000
Q4 2022

Feb 02, 2023

SELL
$7.84 - $11.68 $93,452 - $139,225
-11,920 Reduced 99.17%
100 $0
Q3 2022

Nov 04, 2022

BUY
$10.73 - $20.07 $70,099 - $131,117
6,533 Added 119.06%
12,020 $128,000
Q2 2022

Aug 03, 2022

SELL
$6.76 - $14.18 $386,557 - $810,854
-57,183 Reduced 91.24%
5,487 $59,000
Q1 2022

May 02, 2022

BUY
$11.13 - $23.04 $385,086 - $797,160
34,599 Added 123.26%
62,670 $807,000
Q4 2021

Feb 23, 2022

BUY
$21.81 - $48.96 $333,998 - $749,773
15,314 Added 120.04%
28,071 $620,000
Q3 2021

Oct 28, 2021

BUY
$29.03 - $38.62 $29,204 - $38,851
1,006 Added 8.56%
12,757 $474,000
Q2 2021

Aug 12, 2021

BUY
$32.29 - $39.68 $296,971 - $364,936
9,197 Added 360.1%
11,751 $448,000
Q1 2021

Apr 26, 2021

BUY
$34.75 - $57.5 $88,751 - $146,855
2,554 New
2,554 $94,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.